CLINICAL_TRIALS
trial_result
· 2021-01-08
Clinical Trial Update: ACT34-CMI -- Adult Autologous CD34+ Cells [Phase 2]
Summary
Phase 2 trial update for ACT34-CMI using autologous CD34+ cells in adults with myocardial ischemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lisata Therapeutics, Inc. | Conditions: Myocardial Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2021-01-08